A recent study modified α-fetoprotein (AFP) on DCs, which secrete exosomes carrying AFP, for use in the immunotherapy of hepatocellular carcinoma (HCC) (Lu et al., 2017). This evidence concerns the gene AFP and hepatocellular carcinoma.